Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Gorelik

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Proteins|December 7, 2007
High quality binding modes in docking ligands to proteinsBoris Gorelik, Amiram Goldblum
International Journal of Obesity (2005)|March 11, 2020
The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System DatabaseEinat Gorelik, Boris Gorelik, Reem Masarwa, et al.
Cancer Research|November 1, 2008
Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical modelBoris Gorelik, Irit Ziv, Revital Shohat, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Proteins|December 7, 2007
High quality binding modes in docking ligands to proteinsBoris Gorelik, Amiram Goldblum
International Journal of Obesity (2005)|March 11, 2020
The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System DatabaseEinat Gorelik, Boris Gorelik, Reem Masarwa, et al.
Cancer Research|November 1, 2008
Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical modelBoris Gorelik, Irit Ziv, Revital Shohat, et al.
Pageof 1